Exagen inc. to participate in the canaccord genuity 44th annual growth conference

Carlsbad, calif., aug. 02, 2024 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced its participation in the canaccord genuity 44th annual growth conference, which takes place august 13-15, 2024, at the intercontinental boston hotel in boston, ma. john aballi, exagen's president and chief executive officer will participate in a fireside chat on wednesday, august 14th, at 2:30 pm et. interested parties may access the webcast of the presentation using a link on exagen's website at https://investors.exagen.com/events.
XGN Ratings Summary
XGN Quant Ranking